Navigation Links
FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
Date:5/28/2008

deliver babies after undergoing ExAblate treatment for their uterine fibroids. To date, 17 women delivered healthy infants at term without complications and with an average of seven and a half pounds birth weight. Ten women delivered vaginally and seven delivered by caesarean section. No treatment-related adverse events were reported in those earlier cases.

"As women have children later in their lives, the number of women having pregnancies and uterine fibroids is significant and growing," said Haywood L. Brown, MD, Professor of Obstetrics and Gynecology and chair of the Department of Obstetrics and Gynecology at Duke University Medical Center. "An evidence-based review concluded that if fibroids distort the uterine cavity, there is evidence in favor of removing them to increase pregnancy rates and decrease the rate of miscarriage. Unfortunately, since fibroids that have grown on the wall of the uterus need to be removed by myomectomy, a major abdominal procedure, the morbidity of the intervention may outweigh the benefits of removing the fibroids."

According to Gautam Chaudhuri, MD, Professor of Obstetrics and Gynecology and Chair of the Department of Obstetrics and Gynecology at the University of California, Los Angeles (UCLA) Medical Center, "In a small number of cases, a myomectomy will later require a hysterectomy. In less grave instances, myomectomy carries a risk of post operative adhesions, which may impair a woman's fertility and take time away from trying to become pregnant while she undergoes the procedure and lets her uterus heal. A non-invasive treatment could be a great benefit to women whose fertility issues may be caused by fibroids."

"We're pleased that the FDA has cleared us to start this important study that could potentially impact thousands of women who are struggling to conceive," said Dr. Kobi Vortman, President and Chief Executive Officer of InSightec. "We remain highly committed to moving the treatment paradigm away fro
'/>"/>

SOURCE InSightec Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
2. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
3. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
4. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
5. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
6. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
7. Abbott Presents Long-Term Data From Extension Study Showing Adult Crohns Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
8. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
9. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
10. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
11. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 The global ... 49.12 billion by 2020, growing at a CAGR of ... report by Grand View Research, Inc. Monitoring services is ... from 2014 to 2020.      (Logo: ... with rising incidences of chronic diseases such as cancer, ...
(Date:8/27/2015)...  A recent study by Feucht et al, ... Arthrosurface HemiCAP® Wave implant, which is based on ... implant for isolated patellofemoral disease. While both implant ... scores, none of the patients in the "inlay" ... of the patients in the "onlay" group, showed ...
(Date:8/27/2015)... 27, 2015 Biosimilars are not generics ... U.S. Food and Drug Administration (FDA) for recognizing ... its draft guidance issued today. The FDA,s draft ... distinguishable names, calling for biological products to bear ... This proposal reflects the agency,s thinking that "there ...
Breaking Medicine Technology:mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
... -- At this very moment, FIRMOO is being heatedly discussed ... eyeglasses from FIRMOO are being delivered to various countries of ... so many eyeglasses wearers? In this brand new year of ... platforms, is giving away thousands of free eyeglasses every day ...
... 6, 2012 ViroPharma Incorporated (NASDAQ: ... HALO ) today announced the presentation of positive ... Cinryze® (C1 esterase inhibitor [human]) in combination with ... using Halozyme,s recombinant human hyaluronidase enzyme (rHuPH20), in ...
Cached Medicine Technology:Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 2Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 3ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 2ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 3ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 4ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 5ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 6ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 7ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20) 8
(Date:8/29/2015)... ... August 29, 2015 , ... It can ... protection against dribbled urine and sweat. "In order to prevent these problems, I ... EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal support for a male’s crotch. ...
(Date:8/29/2015)... New York, NY (PRWEB) , ... August 29, 2015 , ... ... the unofficial end of summer (which astronomically, officially ends on September 22nd this year). ... no summer-induced cyber security hangovers linger on which could prove far more costly than ...
(Date:8/29/2015)... ... 29, 2015 , ... The popular television program VOICES IN AMERICA, hosted by ... will be devoting an entire short segment to the subject of diabetes. Diabetes is ... on a daily basis, but recent advancements in medical science may prove to be ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... An online ... decision to make the purchase of CPAP equipment more affordable by offering shipping at ... all types of CPAP products and orders of any size. My Cpap Store is ...
(Date:8/28/2015)... ... August 28, 2015 , ... With the goal of ... for the second year to the Adams County Fairgrounds in Mendon, IL on May ... raise money to support music education in the underfunded school districts of Mendon and ...
Breaking Medicine News(10 mins):Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2
... that supplementing a diet with fish oil can improve health and ... Sports Health: An Multidisciplinary Approach highlights the effects of the omega ... ... (Vocus) December 30, 2008 -- Researchers have firmly established that supplementing ...
... 30 /PRNewswire-Asia-FirstCall/ -- YzApp International,Inc. (the "Company" or ... successfully closed a share exchange transaction with the ... Ltd., a British Virgin,Islands corporation ("New Resources"). ... to execute upon the current,business plan of those ...
... for Excellent Quality, Service, and InnovationHOPKINTON, Mass., Dec. 30 ... world leader in information infrastructure solutions, today announced that ... Management companies in North America, has recognized EMC with ... The IT Supplier of the Year Award recognizes suppliers ...
... start 2009 with less dependency , , TUESDAY, Dec. 30 ... gambling, shopping, smoking, alcohol or more -- people who ... might find help in a new Harvard University publication. ... for breaking unwanted addictive habits. The advice applies universally, ...
... VideoMD.com, a new website that focuses on,physician-generated video ... a milestone of 2500 patient education videos. VideoMD.com would ... and institutions that,have helped to contribute to this milestone. ... the most comprehensive library of health,information videos on the ...
... Inc. (Nasdaq: MYL ) today announced that ... holds a 71.5% controlling interest, received final approval ... December 29, for its Abbreviated New Drug Application (ANDA) ... 30 mg and 40 mg.Stavudine Capsules, indicated for the ...
Cached Medicine News:Health News:Study Shows Fish Oils Dramatically Improve Cholesterol Levels in Professional Football Players 2Health News:Study Shows Fish Oils Dramatically Improve Cholesterol Levels in Professional Football Players 3Health News:New Zealand Wayne's New Resources Development Co., Ltd. Completes Reverse Merger to Go Public in the U.S. 2Health News:New Zealand Wayne's New Resources Development Co., Ltd. Completes Reverse Merger to Go Public in the U.S. 3Health News:EMC Receives Express Scripts' IT Supplier of the Year Award 2Health News:Resolving to Break an Addictive Habit? 2Health News:VideoMD.com Reaches Milestone of 2500 Patient Education Videos 2
... imaging have changed dramatically over the past ... manufacturer of dedicated EP imaging systems that ... requirements. Our EP systems are fully ... needs of EP, Pacemaker and ICD procedures., ...
... Millbrook Practice Manager® is now known ... (PM). Centricity Physician Office - PM is ... and structure, providing an easily adaptable solution ... physician offices of every specialty and ...
... Misys Healthcare Systems offers Misys Tiger, our ... run your practice more efficiently and profitably. ... and custom views harness Misys Tiger's power ... and more physicians are relying on this ...
... Module incorporates an integrated Medical Records ... Technology mandated by the national Health ... easy access to hospital information insurers ... new efficiency with electronic exchange of ...
Medicine Products: